EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity

Yu Shi, Qin Cao, Jingdu Sun, Xiaofang Hu, Zhi Su, Yongchang Xu, Huimin Zhang, Lefu Lan, Youjun Feng iD

PLOS Pathogens · 23.01.2023 · 19 (1) · e1011110

DOI: 10.1371/journal.ppat.1011110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 23.01.2023. Verfasst von Yu Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, …. Hauptthemen laut MEDLINE: Biotin, Pseudomonas Infections. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is an opportunistic pathogen that predominantly causes nosocomial and community-acquired lung infections. As a member of ESKAPE pathogens, carbapenem-resistant P . aeruginosa (CRPA) compromises the limited therapeutic options, raising an urgent demand for the development of lead compounds against previously-unrecognized drug targets. Biotin is an important cofactor, of which the de novo synthesis is an attractive antimicrobial target in certain recalcitrant infections. Here we report genetic and biochemical definition of P . aeruginosa BioH (PA0502) that functions as a gatekeeper enzyme allowing the product pimeloyl-ACP to exit from fatty acid synthesis cycle and to enter the late stage of biotin synthesis pathway. In relative to Escherichia coli , P . aeruginosa physiologically requires 3-fold higher level of cytosolic biotin, which can be attributed to the occurrence of multiple biotinylated enzymes. The BioH protein enables the in vitro reconstitution of biotin synthesis. The repertoire of biotin abundance is assigned to different mouse tissues and/or organ contents, and the plasma biotin level of mouse is around 6-fold higher than that of human. Removal of bioH renders P . aeruginosa biotin auxotrophic and impairs its intra-phagosome persistence. Based on a model of CD-1 mice mimicking the human environment, lung challenge combined with systemic infection suggested that BioH is necessary for the full virulence of P . aeruginosa . As expected, the biotin synthesis inhibitor MAC13772 is capable of dampening the viability of CRPA. Notably, MAC13772 interferes the production of pyocyanin, an important virulence factor of P . aeruginosa . Our data expands our understanding of P . aeruginosa biotin synthesis relevant to bacterial infectivity. In particular, this study represents the first example of an extracellular pathogen P . aeruginosa that exploits biotin cofactor as a fitness determinant, raising the possibility of biotin synthesis as an anti-CRPA target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiotinPseudomonas InfectionsAnimalsHumansMiceAnti-Bacterial AgentsBacterial ProteinsBiosynthetic PathwaysPseudomonas aeruginosa

Substanzen

Anti-Bacterial AgentsBacterial ProteinsBiotin

Autor:innen und Institutionen

  • Department of Microbiology, and Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • College of Animal Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
  • Fuzhou Medical College of Nanchang University, Fuzhou, Jiangxi, China.
  • College of Life Science and Technology, Guangxi University, Nanning, Guangxi, China.

ORCID-Profile: Youjun Feng

Förderung

  • National Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

Shi, Y., Cao, Q., Sun, J., Hu, X., Su, Z., Xu, Y., Zhang, H., Lan, L., & Feng, Y. (2023). The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity. PLOS Pathogens, 19(1), e1011110. https://doi.org/10.1371/journal.ppat.1011110

Vancouver

Shi Y, Cao Q, Sun J, Hu X, Su Z, Xu Y, et al. The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity. PLOS Pathogens. 2023;19(1):e1011110. doi:10.1371/journal.ppat.1011110

BibTeX
@article{Shi2023,
  author = {Shi, Yu and Cao, Qin and Sun, Jingdu and Hu, Xiaofang and Su, Zhi and Xu, Yongchang and Zhang, Huimin and Lan, Lefu and Feng, Youjun},
  title = {The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {1},
  pages = {e1011110},
  doi = {10.1371/journal.ppat.1011110}
}
Kostenlos starten →